Current challenges with PD-L1 testing for immunotherapy biomarkers in non-small cell lung cancer

Y Li, J Chen - Zhonghua bing li xue za zhi= Chinese …, 2019 - pubmed.ncbi.nlm.nih.gov
近年来, 免疫疗法已逐渐成为多种肿瘤的重要治疗策略之一, 其中免疫检查点程序性死亡分子
(PD-1) 及其配体 (PD-L1) 备受关注. PD-L1 是目前最常用的免疫疗效预测生物标志物之一. PD …
被引用次数：1 相关文章

[引用][C] Current challenges with PD-L1 testing for immunotherapy biomarkers in non-small cell lung cancer

Y Li, J Chen - Zhonghua Bing li xue za zhi= Chinese Journal of …, 2019 - europepmc.org
[Current challenges with PD-L1 testing for immunotherapy biomarkers in non-small cell lung
cancer]. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC …